Xponance, Inc. Veracyte, Inc. Transaction History
Xponance, Inc.
- $10.7 Billion
- Q4 2024
A detailed history of Xponance, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 6,490 shares of VCYT stock, worth $218,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,490Holding current value
$218,648% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
76.3MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$277 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$263 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$222 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$142 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$104 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.41B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...